These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
137 related articles for article (PubMed ID: 24132119)
1. Intestinal microsporidiosis due to Enterocytozoon bieneusi in a pediatric kidney transplant recipient successfully treated with fumagillin. Godron A; Accoceberry I; Couret A; Llanas B; Harambat J Transplantation; 2013 Oct; 96(8):e66-7. PubMed ID: 24132119 [No Abstract] [Full Text] [Related]
2. Successful treatment with fumagillin of the first pediatric case of digestive microsporidiosis in a liver-kidney transplant. Desoubeaux G; Maakaroun-Vermesse Z; Lier C; Bailly E; Morio F; Labarthe F; Bernard L; Chandenier J Transpl Infect Dis; 2013 Dec; 15(6):E250-9. PubMed ID: 24298986 [TBL] [Abstract][Full Text] [Related]
3. Microsporidiosis in solid organ transplant recipients: two Enterocytozoon bieneusi cases and review. Lanternier F; Boutboul D; Menotti J; Chandesris MO; Sarfati C; Mamzer Bruneel MF; Calmus Y; Mechaï F; Viard JP; Lecuit M; Bougnoux ME; Lortholary O Transpl Infect Dis; 2009 Feb; 11(1):83-8. PubMed ID: 18803616 [TBL] [Abstract][Full Text] [Related]
4. Fumagillin-induced aseptic meningoencephalitis in a kidney transplant recipient with microsporidiosis. Audemard A; Le Bellec ML; Carluer L; Dargère S; Verdon R; Castrale C; Lobbedez T; Hurault de Ligny B Transpl Infect Dis; 2012 Dec; 14(6):E147-9. PubMed ID: 23025483 [TBL] [Abstract][Full Text] [Related]
5. Fumagillin for intestinal microsporidiosis. Carr A; Cooper DA N Engl J Med; 2002 Oct; 347(17):1381; author reply 1381. PubMed ID: 12397205 [No Abstract] [Full Text] [Related]
6. Potential efficacy of fumagillin in intestinal microsporidiosis due to Enterocytozoon bieneusi in patients with HIV infection: results of a drug screening study. The French Microsporidiosis Study Group. Molina JM; Goguel J; Sarfati C; Chastang C; Desportes-Livage I; Michiels JF; Maslo C; Katlama C; Cotte L; Leport C; Raffi F; Derouin F; Modaï J AIDS; 1997 Nov; 11(13):1603-10. PubMed ID: 9365765 [TBL] [Abstract][Full Text] [Related]
7. Fumagillin treatment of intestinal microsporidiosis. Molina JM; Tourneur M; Sarfati C; Chevret S; de Gouvello A; Gobert JG; Balkan S; Derouin F; N Engl J Med; 2002 Jun; 346(25):1963-9. PubMed ID: 12075057 [TBL] [Abstract][Full Text] [Related]
8. Fumagillin for treatment of intestinal microsporidiosis in renal transplant recipients. Champion L; Durrbach A; Lang P; Delahousse M; Chauvet C; Sarfati C; Glotz D; Molina JM Am J Transplant; 2010 Aug; 10(8):1925-30. PubMed ID: 20636462 [TBL] [Abstract][Full Text] [Related]
9. Development of a real-time polymerase-chain-reaction assay for quantitative detection of Enterocytozoon bieneusi DNA in stool specimens from immunocompromised patients with intestinal microsporidiosis. Menotti J; Cassinat B; Porcher R; Sarfati C; Derouin F; Molina JM J Infect Dis; 2003 May; 187(9):1469-74. PubMed ID: 12717629 [TBL] [Abstract][Full Text] [Related]
11. Microsporidial keratoconjunctivitis treated successfully with a short course of fumagillin. Wilkins JH; Joshi N; Margolis TP; Cevallos V; Dawson CR Eye (Lond); 1994; 8 ( Pt 6)():703-4. PubMed ID: 7867837 [No Abstract] [Full Text] [Related]
12. Trial of oral fumagillin for the treatment of intestinal microsporidiosis in patients with HIV infection. ANRS 054 Study Group. Agence Nationale de Recherche sur le SIDA. Molina JM; Goguel J; Sarfati C; Michiels JF; Desportes-Livage I; Balkan S; Chastang C; Cotte L; Maslo C; Struxiano A; Derouin F; Decazes JM AIDS; 2000 Jul; 14(10):1341-8. PubMed ID: 10930148 [TBL] [Abstract][Full Text] [Related]
14. A preliminary investigation of alternatives to fumagillin for the treatment of Loma salmonae infection in rainbow trout. Speare DJ; Athanassopoulou F; Daley J; Sanchez JG J Comp Pathol; 1999 Oct; 121(3):241-8. PubMed ID: 10486160 [TBL] [Abstract][Full Text] [Related]
15. Therapeutic evaluation of polyamine analogue drug candidates against Enterocytozoon bieneusi in a SCID mouse model. Feng X; Reddy VK; Mayanja-Kizza H; Weiss LM; Marton LJ; Tzipori S Antimicrob Agents Chemother; 2009 Jun; 53(6):2417-23. PubMed ID: 19289524 [TBL] [Abstract][Full Text] [Related]
16. Microsporidiosis: an emerging and opportunistic infection in humans and animals. Didier ES Acta Trop; 2005 Apr; 94(1):61-76. PubMed ID: 15777637 [TBL] [Abstract][Full Text] [Related]
17. Safety and efficacy of fumagillin for the treatment of intestinal microsporidiosis. A French prospective cohort study. Maillard A; Scemla A; Laffy B; Mahloul N; Molina JM J Antimicrob Chemother; 2021 Jan; 76(2):487-494. PubMed ID: 33128055 [TBL] [Abstract][Full Text] [Related]
18. Successful treatment with nitazoxanide of Enterocytozoon bieneusi microsporidiosis in a patient with AIDS. Bicart-Sée A; Massip P; Linas MD; Datry A Antimicrob Agents Chemother; 2000 Jan; 44(1):167-8. PubMed ID: 10602740 [TBL] [Abstract][Full Text] [Related]
19. Epidemiological and clinical study of microsporidiosis in French kidney transplant recipients from 2005 to 2019: TRANS-SPORE registry. Dumond C; Aulagnon F; Etienne I; Heng AE; Bougnoux ME; Favennec L; Kamar N; Iriart X; Pereira B; Büchler M; Desoubeaux G; Kaminski H; Lussac-Sorton F; Gargala G; Anglicheau D; Poirier P; Scemla A; Garrouste C; Transpl Infect Dis; 2021 Oct; 23(5):e13708. PubMed ID: 34324771 [TBL] [Abstract][Full Text] [Related]
20. Therapeutic targets for the treatment of microsporidiosis in humans. Han B; Weiss LM Expert Opin Ther Targets; 2018 Nov; 22(11):903-915. PubMed ID: 30336698 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]